Houston, TX, United States of America

Haoqiang Ying

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beth Israel Deaconess Medical Center, Inc., Dana-Farber-Cancer Institute Inc.. Active years: 2017.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haoqiang Ying: Innovator in Cancer Diagnosis and Treatment

Introduction

Haoqiang Ying is a notable inventor based in Houston, TX, who has made significant contributions to the field of cancer research. His work primarily focuses on methods for diagnosing and treating cancers associated with oncogenic Kras mutations. With a patent portfolio that includes innovative techniques, he is recognized for his efforts in advancing cancer treatment.

Latest Patents

Haoqiang Ying holds a patent titled "Methods for diagnosing and treating oncogenic kras-associated cancer." This patent provides methods for diagnosing and treating cancer associated with an oncogenic Kras mutation in a subject. His innovative approach aims to improve patient outcomes and enhance the effectiveness of cancer therapies.

Career Highlights

Throughout his career, Haoqiang Ying has worked with prestigious institutions such as Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. His experience in these leading research centers has allowed him to collaborate with some of the brightest minds in the field of oncology.

Collaborations

Haoqiang Ying has collaborated with esteemed colleagues, including Ronald A. DePinho and Lewis C. Cantley. These partnerships have fostered a rich environment for innovation and have contributed to the advancement of cancer research.

Conclusion

Haoqiang Ying's contributions to cancer diagnosis and treatment exemplify the impact of innovative research in the medical field. His dedication to improving patient care through his patented methods highlights the importance of ongoing research and collaboration in the fight against cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…